Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Wang Lai. Officer active across 2 companies, notably BeiGene, Ltd.. Aggregated, 34 disclosures have been logged. Split: 0 buy · 23 sells. Total volume traded: €5.3m. Activity tracked since 7 June 2021. The latest transaction was disclosed on 6 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wang Lai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
74 shares@ US$223.23330.5% of flowAmerican Depositary SharesSEC:0001651308-23-000079:0
25 of 34 declarations
About Wang Lai
Wang Lai is an executive at BeiGene, Ltd. and BeOne Medicines Ltd., where he serves as Global Head of R&D and as President, Global Head of R&D. Across 34 filings in total, the 34 sampled filings cover the period from 2021-06-09 to 2026-06-25 and show EUR 0 of purchases and EUR 5,333,772 of sales, with the dominant transaction nature listed as Cession.
